TGFβ INHIBITOR AND PRODRUGS
A compound of formula (I) with improved TGFβ signaling pathway inhibitory activity, improved therapeutic efficacy and improved toxicity profile, as well as two prodrugs thereof are disclosed. Compositions comprising said TGFβ signaling pathway inhibitor and prodrugs thereof are also disclosed. Addit...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
28.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A compound of formula (I) with improved TGFβ signaling pathway inhibitory activity, improved therapeutic efficacy and improved toxicity profile, as well as two prodrugs thereof are disclosed. Compositions comprising said TGFβ signaling pathway inhibitor and prodrugs thereof are also disclosed. Additionally, present invention discloses said compound of formula (I) and prodrugs thereof for use in a method of treating diseases responsive to TGFβ signaling pathway inhibition.
L'invention concerne un composé de formule (I) présentant une activité inhibitrice améliorée de la voie de signalisation du TGFβ, une efficacité thérapeutique améliorée et un profil de toxicité amélioré, ainsi que deux promédicaments associés. L'invention concerne également des compositions comprenant ledit inhibiteur de la voie de signalisation du TGFβ et des promédicaments associés. De plus, la présente invention concerne ledit composé de formule (I) et des promédicaments associés destinés à être utilisés dans une méthode de traitement de maladies sensibles à l'inhibition de la voie de signalisation de TGFβ. |
---|---|
Bibliography: | Application Number: WO2019EP82215 |